장용성 소프트젤 캡슐 시장 : 용도별, 유통 채널별 - 세계 기회 분석과 산업 예측(2023-2032년)

Enteric Softgel Capsules Market By Application (Health Supplements, Pharmaceuticals), By Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drug store, Online Provider): Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,730 ￦ 7,856,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,600 ￦ 13,162,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

장용성 소프트젤 캡슐 시장의 성장은 식이 보충제 채택이 급증하고 장용성 코팅 소프트젤 캡슐과 관련된 장점으로 인해 크게 견인되고 있습니다. 건강에 대한 관심이 높아짐에 따라 건강 보조 식품에 대한 수요가 증가하고 있으며, 이는 건강 보조 식품 산업의 견고한 성장에 기여하고 있습니다. 장용성 소프트젤 캡슐은 정밀하게 조정된 장용성 코팅으로 구별되며, 위장의 가혹한 산성 조건으로부터 섬세한 활성 성분을 보호하면서 전달하기 위한 전략적 솔루션으로 등장했습니다. 이 표적 방출 메커니즘은 장내 흡수를 최적화하여 의약품과 영양소의 생체 이용률(생체 이용률)을 높입니다. 장용성 소프트젤 캡슐은 섬세한 제형에 적용할 수 있으므로 건강 증진 화합물을 효과적이고 효율적으로 전달하고자 하는 제조업체에게 선호되는 선택이 될 수 있습니다.

또한 장용성 코팅 소프트젤 캡슐의 장점은 환자의 순응도를 향상시키고 위장 불편감 발생을 효과적으로 감소시키는 데에도 도움이 됩니다. 부작용을 줄이는 능력은 보충제 및 의약품의 전반적인 내약성을 높이고 일관된 사용을 촉진합니다. 또한 장용성 소프트젤 캡슐은 다양한 제형에 적응할 수 있으므로 의약품 및 건강 보조 식품 용도에서 더욱 인기를 얻고 있습니다. 확장하는 건강 보조 식품 분야와 장용성 코팅 소프트젤 캡슐의 고유한 장점은 시너지 효과를 발휘하며, 효능과 내약성이 우수한 건강 솔루션을 찾는 건강 지향적 소비자의 선호도 변화에 따른 시장 성장을 반영하고 있습니다.

이해관계자 주요 이점

• 이 보고서는 2022-2032년까지 장용성 소프트젤 캡슐 시장 분석 시장 부문, 현재 동향, 추정 및 동향, 역학에 대한 정량적 분석을 제공하여 장용성 소프트젤 캡슐 시장의 유력한 시장 기회를 식별합니다.
• 시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter의 다섯 가지 힘 분석은 이해 관계자가 이익 중심의 비즈니스 결정을 내리고 공급업체와 공급업체의 네트워크를 강화할 수 있도록 구매자와 공급업체의 잠재력을 강조합니다.
• 장용성 소프트젤 캡슐 시장 세분화를 자세히 분석하여 시장 기회를 파악할 수 있습니다.
• 각 지역의 주요 국가는 세계 시장에 대한 매출 기여도에 따라 매핑되어 있습니다.
• 시장 기업의 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 파악할 수 있습니다.
• 이 보고서에는 지역별 및 세계 장용성 소프트젤 캡슐 시장 동향, 주요 기업, 시장 부문, 용도 및 시장 성장 전략에 대한 분석이 포함되어 있습니다.

이 보고서의 커스터마이징이 가능합니다.(추가 비용과 일정이 필요합니다.).

• 규제 가이드라인
• 고객의 관심사에 따른 기업 개요 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 개요 확장 리스트
• 과거 시장 데이터
• 주요 기업 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장의 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회

제4장 장용성 소프트젤 캡슐 시장 : 용도별

• 개요
• 건강보조제
• 의약품

제5장 장용성 소프트젤 캡슐 시장 : 유통 채널별

• 개요
• 슈퍼마켓과 하이퍼마켓
• 약국·드러그스토어
• 온라인 프로바이더

제6장 장용성 소프트젤 캡슐 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 브라질
  • 콜롬비아
  • 아르헨티나
  • 기타 라틴아메리카
• 중동 및 아프리카
  • Gcc
  • 남아프리카
  • 북아프리카
  • 기타

제7장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2022년

제8장 기업 개요

• Catalent, Inc.
• sirio pharma co., ltd.
• Fuji Capsules Co. Ltd.
• InovoBiologic Inc
• NOW Foods Inc.
• Gelita AG.
• Captek Softgel International Inc.
• Viva Pharmaceuticals
• aenova group
• Procaps Group

KSA

영문 목차

영문목차

The growth of the enteric softgel capsules market is strongly driven by the surging adoption of nutraceutical supplements and the benefits associated with enteric-coated softgel capsules. With an escalating focus on health, the demand for nutritional supplements is on the rise, contributing to the robust expansion of the nutraceutical industry. Enteric softgel capsules, distinguished by their precisely tailored enteric coatings, emerge as a strategic solution for delivering delicate active ingredients, safeguarding them from the harsh acidic conditions of the stomach. This targeted release mechanism optimizes absorption in the intestine, thereby elevating the bioavailability of pharmaceuticals and nutrients.The adaptability of enteric softgel capsules to delicate formulations positions them as a preferred choice for manufacturers aiming to ensure the effective and efficient delivery of health-enhancing compounds.

In addition, the merits of enteric-coated softgel capsules extend to enhanced patient compliance, effectively reducing the incidence of gastrointestinal discomfort. The capacity to mitigate side effects fosters greater overall tolerability of supplements and medications, promoting consistent usage. Furthermore, the adaptability of enteric softgel capsules to a diverse array of formulations further propels their popularity across pharmaceutical and nutraceutical applications. The expanding nutraceutical sector and the inherent advantages of enteric-coated softgel capsules synergize seamlessly, reflecting market growth driven by the evolving preferences of health-conscious consumers seeking efficacious and well-tolerated health solutions.

The enteric softgel capsules market is segmented on the basis of application, distribution channel, and region. On the basis of application, the market is segmented into health supplements and pharmaceuticals. On the basis of distribution channel, the market is segmented supermarket & hypermarket, pharmacy & drug store, and online provider. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LA (Brazil, Colombia, Argentina, and rest of LA) and MEA (GCC, South Africa, North Africa and rest of MEA).

The major key players that operate in the global enteric softgel capsules market are Catalent, Inc., Sirio Pharma Co., Ltd., Fuji Capsules Co. Ltd., InovoBiologic Inc, NOW Foods Inc., Gelita AG, CAPTEK Softgel International Inc., Viva Pharmaceutical., Aenova Group, Procaps Group. The key players have adopted product launch as the key strategy to expand their product portfolio.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteric softgel capsules market analysis from 2022 to 2032 to identify the prevailing enteric softgel capsules market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the enteric softgel capsules market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global enteric softgel capsules market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

• Health Supplements
• Pharmaceuticals

By Distribution Channel

• Supermarket and Hypermarket
• Pharmacy and Drug store
• Online Provider

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Colombia
  • Argentina
  • Rest Of La
• Middle East and Africa
  • Gcc
  • South Africa
  • North Africa
  • Rest Of Mea

Key Market Players:

• Catalent, Inc.
• sirio pharma co., ltd.
• Fuji Capsules Co. Ltd.
• InovoBiologic Inc
• NOW Foods Inc.
• Gelita AG.
• Captek Softgel International Inc.
• Viva Pharmaceuticals
• aenova group
• Procaps Group

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
• 3.4. Market dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Health Supplements
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Pharmaceuticals
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Supermarket and Hypermarket
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Pharmacy and Drug store
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Online Provider
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country

CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET, BY REGION

• 6.1. Overview
  • 6.1.1. Market size and forecast By Region
• 6.2. North America
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by Application
  • 6.2.3. Market size and forecast, by Distribution Channel
  • 6.2.4. Market size and forecast, by country
    • 6.2.4.1. U.S.
    • 6.2.4.1.1. Market size and forecast, by Application
    • 6.2.4.1.2. Market size and forecast, by Distribution Channel
    • 6.2.4.2. Canada
    • 6.2.4.2.1. Market size and forecast, by Application
    • 6.2.4.2.2. Market size and forecast, by Distribution Channel
    • 6.2.4.3. Mexico
    • 6.2.4.3.1. Market size and forecast, by Application
    • 6.2.4.3.2. Market size and forecast, by Distribution Channel
• 6.3. Europe
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by Application
  • 6.3.3. Market size and forecast, by Distribution Channel
  • 6.3.4. Market size and forecast, by country
    • 6.3.4.1. Germany
    • 6.3.4.1.1. Market size and forecast, by Application
    • 6.3.4.1.2. Market size and forecast, by Distribution Channel
    • 6.3.4.2. France
    • 6.3.4.2.1. Market size and forecast, by Application
    • 6.3.4.2.2. Market size and forecast, by Distribution Channel
    • 6.3.4.3. UK
    • 6.3.4.3.1. Market size and forecast, by Application
    • 6.3.4.3.2. Market size and forecast, by Distribution Channel
    • 6.3.4.4. Italy
    • 6.3.4.4.1. Market size and forecast, by Application
    • 6.3.4.4.2. Market size and forecast, by Distribution Channel
    • 6.3.4.5. Spain
    • 6.3.4.5.1. Market size and forecast, by Application
    • 6.3.4.5.2. Market size and forecast, by Distribution Channel
    • 6.3.4.6. Rest of Europe
    • 6.3.4.6.1. Market size and forecast, by Application
    • 6.3.4.6.2. Market size and forecast, by Distribution Channel
• 6.4. Asia-Pacific
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by Application
  • 6.4.3. Market size and forecast, by Distribution Channel
  • 6.4.4. Market size and forecast, by country
    • 6.4.4.1. Japan
    • 6.4.4.1.1. Market size and forecast, by Application
    • 6.4.4.1.2. Market size and forecast, by Distribution Channel
    • 6.4.4.2. China
    • 6.4.4.2.1. Market size and forecast, by Application
    • 6.4.4.2.2. Market size and forecast, by Distribution Channel
    • 6.4.4.3. India
    • 6.4.4.3.1. Market size and forecast, by Application
    • 6.4.4.3.2. Market size and forecast, by Distribution Channel
    • 6.4.4.4. Australia
    • 6.4.4.4.1. Market size and forecast, by Application
    • 6.4.4.4.2. Market size and forecast, by Distribution Channel
    • 6.4.4.5. South Korea
    • 6.4.4.5.1. Market size and forecast, by Application
    • 6.4.4.5.2. Market size and forecast, by Distribution Channel
    • 6.4.4.6. Rest of Asia-Pacific
    • 6.4.4.6.1. Market size and forecast, by Application
    • 6.4.4.6.2. Market size and forecast, by Distribution Channel
• 6.5. Latin America
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by Application
  • 6.5.3. Market size and forecast, by Distribution Channel
  • 6.5.4. Market size and forecast, by country
    • 6.5.4.1. Brazil
    • 6.5.4.1.1. Market size and forecast, by Application
    • 6.5.4.1.2. Market size and forecast, by Distribution Channel
    • 6.5.4.2. Colombia
    • 6.5.4.2.1. Market size and forecast, by Application
    • 6.5.4.2.2. Market size and forecast, by Distribution Channel
    • 6.5.4.3. Argentina
    • 6.5.4.3.1. Market size and forecast, by Application
    • 6.5.4.3.2. Market size and forecast, by Distribution Channel
    • 6.5.4.4. Rest Of La
    • 6.5.4.4.1. Market size and forecast, by Application
    • 6.5.4.4.2. Market size and forecast, by Distribution Channel
• 6.6. Middle East and Africa
  • 6.6.1. Key market trends, growth factors and opportunities
  • 6.6.2. Market size and forecast, by Application
  • 6.6.3. Market size and forecast, by Distribution Channel
  • 6.6.4. Market size and forecast, by country
    • 6.6.4.1. Gcc
    • 6.6.4.1.1. Market size and forecast, by Application
    • 6.6.4.1.2. Market size and forecast, by Distribution Channel
    • 6.6.4.2. South Africa
    • 6.6.4.2.1. Market size and forecast, by Application
    • 6.6.4.2.2. Market size and forecast, by Distribution Channel
    • 6.6.4.3. North Africa
    • 6.6.4.3.1. Market size and forecast, by Application
    • 6.6.4.3.2. Market size and forecast, by Distribution Channel
    • 6.6.4.4. Rest Of Mea
    • 6.6.4.4.1. Market size and forecast, by Application
    • 6.6.4.4.2. Market size and forecast, by Distribution Channel

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top winning strategies
• 7.3. Product mapping of top 10 player
• 7.4. Competitive dashboard
• 7.5. Competitive heatmap
• 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

• 8.1. Catalent, Inc.
  • 8.1.1. Company overview
  • 8.1.2. Key executives
  • 8.1.3. Company snapshot
  • 8.1.4. Operating business segments
  • 8.1.5. Product portfolio
  • 8.1.6. Business performance
  • 8.1.7. Key strategic moves and developments
• 8.2. sirio pharma co., ltd.
  • 8.2.1. Company overview
  • 8.2.2. Key executives
  • 8.2.3. Company snapshot
  • 8.2.4. Operating business segments
  • 8.2.5. Product portfolio
  • 8.2.6. Business performance
  • 8.2.7. Key strategic moves and developments
• 8.3. Fuji Capsules Co. Ltd.
  • 8.3.1. Company overview
  • 8.3.2. Key executives
  • 8.3.3. Company snapshot
  • 8.3.4. Operating business segments
  • 8.3.5. Product portfolio
  • 8.3.6. Business performance
  • 8.3.7. Key strategic moves and developments
• 8.4. InovoBiologic Inc
  • 8.4.1. Company overview
  • 8.4.2. Key executives
  • 8.4.3. Company snapshot
  • 8.4.4. Operating business segments
  • 8.4.5. Product portfolio
  • 8.4.6. Business performance
  • 8.4.7. Key strategic moves and developments
• 8.5. NOW Foods Inc.
  • 8.5.1. Company overview
  • 8.5.2. Key executives
  • 8.5.3. Company snapshot
  • 8.5.4. Operating business segments
  • 8.5.5. Product portfolio
  • 8.5.6. Business performance
  • 8.5.7. Key strategic moves and developments
• 8.6. Gelita AG.
  • 8.6.1. Company overview
  • 8.6.2. Key executives
  • 8.6.3. Company snapshot
  • 8.6.4. Operating business segments
  • 8.6.5. Product portfolio
  • 8.6.6. Business performance
  • 8.6.7. Key strategic moves and developments
• 8.7. Captek Softgel International Inc.
  • 8.7.1. Company overview
  • 8.7.2. Key executives
  • 8.7.3. Company snapshot
  • 8.7.4. Operating business segments
  • 8.7.5. Product portfolio
  • 8.7.6. Business performance
  • 8.7.7. Key strategic moves and developments
• 8.8. Viva Pharmaceuticals
  • 8.8.1. Company overview
  • 8.8.2. Key executives
  • 8.8.3. Company snapshot
  • 8.8.4. Operating business segments
  • 8.8.5. Product portfolio
  • 8.8.6. Business performance
  • 8.8.7. Key strategic moves and developments
• 8.9. aenova group
  • 8.9.1. Company overview
  • 8.9.2. Key executives
  • 8.9.3. Company snapshot
  • 8.9.4. Operating business segments
  • 8.9.5. Product portfolio
  • 8.9.6. Business performance
  • 8.9.7. Key strategic moves and developments
• 8.10. Procaps Group
  • 8.10.1. Company overview
  • 8.10.2. Key executives
  • 8.10.3. Company snapshot
  • 8.10.4. Operating business segments
  • 8.10.5. Product portfolio
  • 8.10.6. Business performance
  • 8.10.7. Key strategic moves and developments

관련자료